Refine by MP, party, committee, province, or result type.
Public Accounts committee That's not what I said. Thank you.
March 23rd, 2023Committee meeting
Jean-Pierre Baylet
Public Accounts committee Not to my knowledge.
March 23rd, 2023Committee meeting
Jean-Pierre Baylet
Public Accounts committee Mr. Chair, we recognize that we have to respect laws, and we respect laws wherever we operate. As far as the competency of the committee to review an unredacted version of the contract of Sanofi is concerned, I cannot answer that question.
March 23rd, 2023Committee meeting
Jean-Pierre Baylet
Public Accounts committee Protection for our intellectual property also allows us to continue to carry out our Canadian operations securely. It's very important to safeguard the future of jobs and investments. I believe that is where the core of the discussion lies, by which I mean continuing to ensure confidentiality.
March 23rd, 2023Committee meeting
Jean-Pierre Baylet
Public Accounts committee Thank you again for the question, Ms. Sinclair-Desgagné. I haven't changed my mind. I respect your opinion….
March 23rd, 2023Committee meeting
Jean-Pierre Baylet
Public Accounts committee I am stubborn.
March 23rd, 2023Committee meeting
Jean-Pierre Baylet
Public Accounts committee To my knowledge, no unredacted versions have been sent to a Parliament in any other country around the world. If I may, I can verify this with our legal teams and share the information with you in the next few days.
March 23rd, 2023Committee meeting
Jean-Pierre Baylet
Public Accounts committee Sanofi only entered into that agreement after an extremely thorough competitive process. Disclosing information from the contract could put us in a difficult situation. The pandemic isn't over yet and negotiations are currently underway in other countries. So, of course, we don't want the contract information to be made public.
March 23rd, 2023Committee meeting
Jean-Pierre Baylet
Public Accounts committee I respect your position, but I maintain that Sanofi doesn't want the contract information disclosed to the committee. We believe it's a matter of balancing the need for transparency with the need to respect the confidentiality of the contract.
March 23rd, 2023Committee meeting
Jean-Pierre Baylet
Public Accounts committee We believe that the role and mission of the Auditor General of Canada and her office have been respected—
March 23rd, 2023Committee meeting
Jean-Pierre Baylet
Public Accounts committee I read through the Auditor General of Canada's website. It says—
March 23rd, 2023Committee meeting
Jean-Pierre Baylet
Public Accounts committee I have to say that the Auditor General reports to Parliament. Sanofi has been transparent, and we believe that we've provided the information we felt we needed to provide.
March 23rd, 2023Committee meeting
Jean-Pierre Baylet
Public Accounts committee Thank you.
March 23rd, 2023Committee meeting
Jean-Pierre Baylet
Public Accounts committee Thank you for your question, Mrs. Shanahan. To our knowledge, only redacted versions were released by Sanofi in other countries.
March 23rd, 2023Committee meeting
Jean-Pierre Baylet
Public Accounts committee Mr. Chair, hon. members of the Standing Committee on Public Accounts, good afternoon. My name is Jean‑Pierre Baylet, and I'm general manager of the vaccines unit at Sanofi Canada. Sanofi is an innovative global health care company. It is driven by one calling: Pursue the miracles of science to improve people's lives.
March 23rd, 2023Committee meeting
Jean-Pierre Baylet